Vir Biotechnology VIR paid Forbes-Tate $80K for lobbying in Q4 2022 · Health Issues, Government Issues and 2 more issues

Trade details

Type: Lobbying report
Amount: $80,000
Quarter: Q4 2022
Stock: Vir Biotechnology VIR
Client: Vir Biotechnology
Reported: 23/01/17

$270K on lobbying in 2022

What else happened in Vir Biotechnology around then

Filed or reported within 30 days of the trade day · 22/12/01~23/01/30

Vir Biotechnology's other lobbying reports

Vir Biotechnology
LobbyingVir Biotechnology
Lobbying
Vir Biotechnology
VIR
$50K
$50K
Reported 07/20
for Q2
Vir Biotechnology
LobbyingVir Biotechnology
Lobbying
Vir Biotechnology
VIR
$50K
$50K
Reported 04/19
for Q1
Vir Biotechnology
LobbyingVir Biotechnology
Lobbying
Vir Biotechnology
VIR
$50K
$50K
Reported 01/17
for Q4 2025
Vir Biotechnology
LobbyingVir Biotechnology
Lobbying
Vir Biotechnology
VIR
$50K
$50K
Reported 25/10/18
for Q3 2025
Vir Biotechnology
LobbyingVir Biotechnology
Lobbying
Vir Biotechnology
VIR
$50K
$50K
Reported 25/07/18
for Q2 2025

Vir Biotechnology VIR paid Forbes-Tate $80K for lobbying in Q4 2022 · Health Issues, Government Issues and 2 more issues | Whalegun